Pfizer Q1 2026 Earnings Beat: Growth Drivers and Outlook

Pfizer just posted better-than-expected Q1 results and stuck to its full-year guidance despite Covid product declines. But what really stands...

06/05/2026

1 views

…

Morgan Stanley just upgraded Johnson & Johnson to Overweight, raising the price target to $262 on the back of an...

28/01/2026

1 views

The JPM Healthcare Conference kicks off next week, and pharma leaders are ready to reveal their 2026 strategies. From massive...

09/01/2026

10 views

Rigel Pharmaceuticals shares leaped almost 50% in just three months, with the CEO boasting substantial business growth and profitability. What’s...

30/10/2025

6 views

Ionis Pharmaceuticals’ stock is skyrocketing, fueled by a promising drug pipeline. What’s driving this biotech’s rise, and is it time...

08/10/2025

2 views